PATENT CLAIM ANALYSIS

Application Number: 15945334
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["544", "335000"]

Abstract:
The instant invention describes compounds of Formula I having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

Claim (Index 21):
The method according to  claim 20 , wherein the disease or disorder is cancer, cardiovascular disease, endocrinologic disease, inflammatory disease, infectious disease, gynecologic disease, metabolic disease, opthalmologic disease, central nervous system (CNS) disease, urologic disease, or gastrointestinal disease.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.07692
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14683907', '15914884', '14683857', '15586657', '13528283']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8251595990399528
- 35 USC 102 Novelty (BERT): 0.5407271948097908
- Combined Prediction Score: 0.7967163586169366
- Mean Citation Score: 387.547346
- Max Citation Score: 425.4644
- Similarity Product: 247.9363708363533

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test